Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort
- PMID: 24332537
- DOI: 10.1016/j.ophtha.2013.10.043
Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort
Erratum in
- Ophthalmology. 2015 Apr;122(4):868
Abstract
Purpose: To assess the 15-year incidence and progression of reticular drusen and associations of this lesion with age-related macular degeneration (AMD) risk factors.
Design: Population-based cohort.
Participants: Blue Mountains Eye Study participants (n = 3654) 49 years of age and older attended baseline examinations; of these, 75.8%, 76.7%, and 56.1% of survivors attended 5-year, 10-year, and 15-year follow-up examinations, respectively.
Methods: Color retinal photographs were obtained and comprehensive questionnaires were administered at each visit, and DNA samples were genotyped. Fundus autofluorescence images were not available. Reticular drusen identified from photographs were confirmed with side-by-side grading using the Wisconsin AMD grading protocol. Incidence was assessed using Kaplan-Meier product limit survival methods, controlling for competing risk of death. Associations between smoking, fish consumption, serum lipids, systemic and dietary factors, the CFH single nucleotide polymorphism (SNP) rs1061170 and ARMS2 SNP rs10490924, and the 15-year incidence of reticular drusen were analyzed in discrete logistic regression models. Generalized estimating equation models were used to analyze eye-specific relationships between these risk factors and 5-year progression from reticular drusen to late AMD.
Main outcome measures: Incidence and progression of reticular drusen.
Results: The 15-year cumulative incidence of reticular drusen was 4.0% (n = 95). Increasing age (per decade increase; odds ratio [OR], 3.4; 95% confidence interval [CI], 2.6-4.4), female sex (OR, 2.0; 95% CI, 1.3-3.2), and presence of risk alleles of CFH-rs1061170 (OR, 1.8; 95% CI, 1.3-2.4) or ARMS2-rs10490924 (OR, 3.0; 95% CI, 2.1-4.4) were associated with higher reticular drusen incidence. Current smoking at baseline predicted higher reticular drusen incidence (OR 2.1, 95% CI 1.0-4.5) after adjusting for age, sex, CFH-rs1061170 and ARMS2-rs10490924 polymorphisms. Of 118 eyes with reticular drusen, 40 (33.9%) developed late AMD over 5 years. A higher proportion of eyes with reticular drusen located outside versus within the macular area progressed to late AMD (50.0% vs. 37.8%). Dietary lutein-zeaxanthin intake was associated with decreased likelihood of progression from reticular drusen to late AMD (adjusted OR, 0.5; 95% CI, 0.3-1.0).
Conclusions: Known AMD risk factors were associated with greater long-term risk of reticular drusen. Neither total area nor central location of reticular drusen predicted 5-year progression to late AMD. Increased consumption of lutein-zeaxanthin predicted a lower risk of progression.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Incidence, Progression, and Associated Risk Factors of Medium Drusen in Age-Related Macular Degeneration: Findings From the 15-Year Follow-up of an Australian Cohort.JAMA Ophthalmol. 2015 Jun;133(6):698-705. doi: 10.1001/jamaophthalmol.2015.0498. JAMA Ophthalmol. 2015. PMID: 25838066
-
The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.Ophthalmology. 2015 Dec;122(12):2482-9. doi: 10.1016/j.ophtha.2015.08.002. Epub 2015 Sep 14. Ophthalmology. 2015. PMID: 26383995
-
Incidence and progression of geographic atrophy: observations from a population-based cohort.Ophthalmology. 2013 Oct;120(10):2042-50. doi: 10.1016/j.ophtha.2013.03.029. Epub 2013 May 22. Ophthalmology. 2013. PMID: 23706948
-
Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.Acta Ophthalmol. 2018 Mar;96(2):e105-e110. doi: 10.1111/aos.13494. Epub 2017 Jun 8. Acta Ophthalmol. 2018. PMID: 28593728 Review.
-
The association between complement factor H rs1061170 polymorphism and age-related macular degeneration: a comprehensive meta-analysis stratified by stage of disease and ethnicity.Acta Ophthalmol. 2019 Feb;97(1):e8-e21. doi: 10.1111/aos.13849. Epub 2018 Oct 2. Acta Ophthalmol. 2019. PMID: 30280493
Cited by
-
Enhanced Detection of Reticular Pseudodrusen on Color Fundus Photos by Image Embossing.Curr Eye Res. 2022 Nov;47(11):1547-1552. doi: 10.1080/02713683.2022.2126860. Epub 2022 Oct 2. Curr Eye Res. 2022. PMID: 36183241 Free PMC article.
-
Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging.BMJ Open Ophthalmol. 2020 Jan 14;5(1):e000361. doi: 10.1136/bmjophth-2019-000361. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 32509962 Free PMC article.
-
Increased Systemic C-Reactive Protein Is Associated With Choroidal Thinning in Intermediate Age-Related Macular Degeneration.Transl Vis Sci Technol. 2021 Oct 4;10(12):7. doi: 10.1167/tvst.10.12.7. Transl Vis Sci Technol. 2021. PMID: 34609476 Free PMC article.
-
Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment.Cells. 2023 Jun 23;12(13):1708. doi: 10.3390/cells12131708. Cells. 2023. PMID: 37443742 Free PMC article. Review.
-
Reticular Pseudodrusen Characteristics and Associations in the Carotenoids in Age-Related Eye Disease Study 2 (CAREDS2), an Ancillary Study of the Women's Health Initiative.Ophthalmol Retina. 2021 Aug;5(8):721-729. doi: 10.1016/j.oret.2020.12.019. Epub 2020 Dec 30. Ophthalmol Retina. 2021. PMID: 33387684 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous